logo
15:47 May 29

Wanbury Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
308.65
+8.45 (+2.81%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Wanbury Ltd. Financials

Wanbury Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
308.65
+8.45 (+2.81%)
15:47 May 29
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

50/100
Mid Valuation

Technical

66/100
Technically Moderately Bullish

Strength

9

Weakness

5

Opportunity

0

Threats

0

51.50 %

ROE %

7.37 %

ROA %

18.93

EPS

18.09

BVPS

5.09 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
392.52 511.19 499.65 575.65 599.51
Operating Expenses +
374.51 475.87 476.48 505.65 523.2
Raw Material
224.35 325.07 273.46 306.52 292.96
Increase Decrease in Cost
-7.2 -24.79 29.13 -3.89 1.51
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
64.15 74.81 81 86.92 104.24
Miscellaneous Expenses
114.51 141.06 124.85 150.7 154.65
Operating Profit
18.01 35.32 23.17 70 76.31
Other Income
2.4 1.51 0.91 2.99 3.49
Depreciation
9.75 11.45 12.38 13.03 13.31
Interest
23.07 20.61 21.39 29.18 36.95
Profit before tax and exceptio..
-12.41 4.76 -9.69 30.78 29.55
Exceptional Items
0 76.37 -0.59 25.56 0
PBT
-12.41 81.13 -10.29 56.34 29.55
Provision for Taxation
0.2 -0.35 0.11 0.38 -0.98
Net Profit
-12.61 81.47 -10.4 55.96 30.53
NET Profit after MI
-12.61 81.47 -10.4 55.96 30.53
EPS
-5.04 25.29 -3.18 17.1 9.32
Operating Profit Margin (%)
4.59 6.91 4.64 12.16 12.73
Net Profit Margin (%)
-3.21 15.94 -2.08 9.72 5.09

Wanbury Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 43.00 43.10 39.60 39.60 39.80 39.80
FII 0.60 0.70 0.80 1.60 1.60 0.80
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 56.40 56.20 59.60 58.80 58.60 59.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: